Author(s):
Prakash M. Somade, Pramod Anil Patil, Suraj N. Mali, Pratibha S. Gavarkar, Rohan Sharadanand Phatak, Rajashree S. Chavan, Atul R. Chopade
Email(s):
prithvirajpatil87@gmail.com
DOI:
10.52711/0974-360X.2023.00006
Address:
Prakash M. Somade1, Pramod Anil Patil2, Suraj N. Mali3, Pratibha S. Gavarkar4, Rohan Sharadanand Phatak1, Rajashree S. Chavan5, Atul R. Chopade2
1Krishna Institute of Medical Science "Deemed to be University", Karad - 415539, Maharashtra.
2Rajarambapu College of Pharmacy, Kasegaon, District – Sangli, Maharashtra, 415404. India.
3Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology Mesra, Ranchi, (Jharkhand) 835215 India.
4Dept. of Pharmaceutical Chemistry, Anandi Pharmacy College, Kalambe tarf Kale, Tal - Karveer, Dist- Kolhapur 416205.
5Principal, Seth Govind Raghunath Sable College of Pharmacy, Saswad, Dist - Pune, Tal - Purandar 412301.
*Corresponding Author
Published In:
Volume - 16,
Issue - 1,
Year - 2023
ABSTRACT:
Main aim of study is to investigate the Rubiadin effects in mice model of chronic inflammation and pain. Complete Freund’s adjuvant (CFA) inflammatory model was used for investigation of chronic hypersensitivity. Prior CFA inflammation, Von Frey filaments and acetone induced cold sensitivity test was used to evaluate hypersensitivity, respectively. The paw edema was measured using digital plethysmometer. Intraperitoneally administered Rubiadin (100 and 200mg/kg) prior testing reduced CFA induced mechanical hypersensitivity. Rubiadin reduces evoked acetone cold hypersensitivity. Compared with vehicle, Rubiadin reduces paw edema too. Rubiadin reduced mechanical hypersensitivity significantly when administered two times a day from first to fifth day and from ninth to tenth day. In conclusion study revealed Rubiadin anti-nociceptive activity in chronic pain and also might be potential for effective management of pain.
Cite this article:
Prakash M. Somade, Pramod Anil Patil, Suraj N. Mali, Pratibha S. Gavarkar, Rohan Sharadanand Phatak, Rajashree S. Chavan, Atul R. Chopade. Antinociceptive Investigations of Rubiadin in Chronic pain induced by Freund’s adjuvant in mice. Research Journal of Pharmacy and Technology 2023; 16(1):31-4. doi: 10.52711/0974-360X.2023.00006
Cite(Electronic):
Prakash M. Somade, Pramod Anil Patil, Suraj N. Mali, Pratibha S. Gavarkar, Rohan Sharadanand Phatak, Rajashree S. Chavan, Atul R. Chopade. Antinociceptive Investigations of Rubiadin in Chronic pain induced by Freund’s adjuvant in mice. Research Journal of Pharmacy and Technology 2023; 16(1):31-4. doi: 10.52711/0974-360X.2023.00006 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-1-6
REFERENCES:
1. Bhopale NM. Aswar PB. Banarase NB. Khadabadi SS. Design, Development and In-vitro Evaluation of Sustain Release Rubia cordifolia Matrix Tablet. Research Journal of Pharmacy and Technology 2008;1(4):475-7.
2. Khodke AS. Potale LV. Patole SM. Damle MC. A Validated RP-HPLC Method Development for Determination of Anthraquinone Marker from the Roots of Rubia cordifolia Linn. Research Journal of Pharmacy and Technology 2011;4(2):326-8.
3. Victorovna RM. Alexandrovich KV. Anatolyevna SA. Nikolayevich SA. Development of a method of quantitative determination of rhizome and roots of rubia cordifolium. Research Journal of Pharmacy and Technology 2019;12(11):5338-40.
4. Kamani G. Sanghani R. Savalia V. Pandya D. Detection of adulteration in Rubia cordifolia-A chromatographic approach. Research Journal of Pharmacy and Technology 2021;14(8):4013-8.
5. Anup K. Mohan K. Suraj S. Sandip F. Bhushan F. Prashant W. Antimicrobial activity of some important medicinal plants of India against some plant and human pathogens. Research Journal of Pharmacy and Technology 2010;3(3):924-6.
6. Gorle A. Patil S. Development and evaluation of Rubia cordifolia gel for treatment of acne. Research Journal of Topical and Cosmetic Sciences 2018;9(2):39-43.
7. Praveena A. Ramkumar G. Sanjayan KP. Phytochemical screening of the extract of the root-bark of Morinda tinctoria (Rubiaceae) for secondary metabolites. Research Journal of Pharmacy and Technology 2012;5(1):83-7.
8. Antarkar SS. Chinwalla T. Bhatt N. Anti-inflammatory activity of Rubia cordifolia Linn. in rats. Indian J Pharmacol. 1983;15(3):185-8.
9. Joharapurkar AA. Deode NM. Zambad SP. Umathe SN. Immunomodulatory activity of alcoholic extract of Rubia cordifolia Linn. Indian Drugs 2003;40(3):179-81.
10. Chopade AR. Sayyad FJ. Analysis of the central and peripheral mechanisms underlying the analgesic effects of the extracts of Phyllanthus amarus and Phyllanthus fraternus. Asian Journal of Pharmaceutical Research 2013;3(1):10-4.
11. Shen CH. Liu CT. Song XJ. Zeng WY. Lu XY. Zheng ZL. Zhan RT. Evaluation of analgesic and anti-inflammatory activities of Rubia cordifolia L. by spectrum-effect relationships. Journal of Chromatography B. 2018; 1090:73-80.
12. Chopade A.R. Sayyad F.J. Evaluation of membrane stabilizing and inhibition of protein denaturation activity of Phyllanthus fraternus Webster. Research Journal of Pharmacy and Technology 2013 6(3); 251-254.
13. Chopade AR. Salunkhe VR. Patil PA. Burade MR. Somade PM. Mali SN. et al. Antinociceptive Investigations of Niranthin in Complete Freund's Adjuvant-induced Chronic Pain in Mice. Recent Advances in Inflammation and Allergy Drug Discovery. 2022.
14. Gunasekaran B. Muralidharan P. Antinociceptive effect of Abutilon indicum Linn leaf extract. Research Journal of Pharmacy and Technology 2009;2(3):544-7.
15. Swarnkar SK. Khunteta A. Dheer R. Gupta MK. Jain PK. Sharma S. Paliwal S. Evaluation of Impact of Hydro-alcoholic Extract and Ethyl Acetate Fraction of Flowering Tops of “Desert Cotton” plant on Analgesic, Pyretic and Inflammatory Murine Models. Research Journal of Pharmacy and Technology 2020;13(4):1645-50.
16. Anuse DG. Mali SN. Thorat BR. Yamgar RS. Chaudhari HK. Synthesis, SAR, in silico appraisal and anti-microbial study of substituted 2-aminobenzothiazoles derivatives. Current computer-aided drug design 2020 ;16(6):802-13.
17. Desale VJ. Mali SN. Chaudhari HK. Mali MC. Thorat BR. Yamgar RS. Synthesis and Anti-mycobacterium Study on Halo-substituted 2-aryl oxyacetohydrazones. Current computer-aided drug design 2020;16(5):618-28.
18. Jejurkar VP. Mali SN. Kshatriya R. Chaudhari HK. Saha S. Synthesis, antimicrobial screening and in silico appraisal of iminocarbazole derivatives. ChemistrySelect. 2019;4(32):9470-5.
19. Mali SN. Pandey A. Balanced QSAR and molecular modeling to identify structural requirements of imidazopyridine analogues as anti-infective agents against trypanosomiases. Journal of Computational Biophysics and Chemistry 2021:1-32.
20. Mali SN. Pandey A. Molecular modeling studies on 2, 4-disubstituted imidazopyridines as anti-malarials: atom-based 3D-QSAR, molecular docking, virtual screening, in-silico ADMET and theoretical analysis. Journal of Computational Biophysics and Chemistry. 2021;20(03):267-82.
21. Mali SN. Pandey A. Thorat BR. Lai CH. Multiple 3D-and 2D-quantitative structure–activity relationship models (QSAR), theoretical study and molecular modeling to identify structural requirements of imidazopyridine analogues as anti-infective agents against tuberculosis. Structural Chemistry. 2022:1-6.